Chantix Heart Problems Being Reviewed in Canada
Canadian officials have launched a review into the potential risk of heart problems from Chantix, Pfizer’s smoking cessation drug, which has been linked to an increased risk of heart attacks…
Canadian officials have launched a review into the potential risk of heart problems from Chantix, Pfizer’s smoking cessation drug, which has been linked to an increased risk of heart attacks…
Increasing questions over serious and potentially life-threatning psychological side effects of Chantix, Pfizer’s smoking cessation drug, have convinced officials in France that the drug should no longer be subsidized in…
Demand for the smoking cessation drug Chantix is skyrocketing in Japan, following a recent tax increase on cigarettes and due to a lack of publicity about the drug’s links to…
A New Zealand government agency has reversed it’s position regarding the safety of Pfizer’s stop-smoking drug Chantix, despite concerns that the medication, which is marketed as Champix in that country,…
A class action lawsuit has been filed in Canada by three women from British Columbia who say that Pfizer did not give enough warning about the suicidal tendencies caused by…
Health Canada has issued a reminder about the potential suicide side effects associated with Champix, the Canadian version of the stop-smoking drug Chantix. Suicides and other psychiatric side effects have…
The British Government has released data confirming that users of Champix, the European version of the stop-smoking drug known as Chantix in the United States, have been reporting a number…